🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/07/1991 | 19,08 | 19,48 | 19,04 | 19,34 | +1,46% | 2,29% | 4.133.731 |
| 12/07/1991 | 19,00 | 19,12 | 18,79 | 19,06 | +1,27% | 1,78% | 3.169.781 |
| 11/07/1991 | 18,75 | 18,85 | 18,69 | 18,83 | +0,74% | 0,85% | 3.207.509 |
| 10/07/1991 | 18,77 | 18,91 | 18,67 | 18,69 | -0,32% | 1,27% | 3.094.954 |
| 09/07/1991 | 18,92 | 18,96 | 18,63 | 18,75 | -1,36% | 1,79% | 2.386.296 |
| 08/07/1991 | 18,53 | 19,00 | 18,45 | 19,00 | +1,59% | 3,00% | 2.868.586 |
| 05/07/1991 | 18,59 | 18,81 | 18,57 | 18,71 | +0,32% | 1,28% | 1.228.675 |
| 03/07/1991 | 18,77 | 18,79 | 18,61 | 18,65 | -1,78% | 0,95% | 2.136.662 |
| 02/07/1991 | 18,92 | 19,02 | 18,91 | 18,98 | +0,10% | 0,63% | 2.801.304 |
| 01/07/1991 | 18,57 | 18,96 | 18,57 | 18,96 | +2,69% | 2,14% | 3.656.472 |
| 28/06/1991 | 18,77 | 18,81 | 18,39 | 18,47 | -2,00% | 2,22% | 3.513.106 |
| 27/06/1991 | 18,77 | 18,89 | 18,75 | 18,85 | +0,74% | 0,74% | 2.584.368 |
| 26/06/1991 | 18,57 | 18,81 | 18,51 | 18,71 | +0,86% | 1,61% | 4.310.424 |
| 25/06/1991 | 18,27 | 18,55 | 18,23 | 18,55 | +1,97% | 1,74% | 3.579.130 |
| 24/06/1991 | 18,41 | 18,41 | 18,17 | 18,19 | -1,61% | 1,30% | 2.217.149 |
| 21/06/1991 | 18,43 | 18,51 | 18,35 | 18,49 | +0,32% | 0,86% | 6.507.451 |
| 20/06/1991 | 18,35 | 18,49 | 18,33 | 18,43 | +0,22% | 0,87% | 4.009.229 |
| 19/06/1991 | 18,45 | 18,45 | 18,25 | 18,39 | -0,75% | 1,08% | 3.879.067 |
| 18/06/1991 | 18,75 | 18,81 | 18,51 | 18,53 | -1,38% | 1,59% | 3.155.318 |
| 17/06/1991 | 18,77 | 18,79 | 18,63 | 18,79 | -0,11% | 0,85% | 2.635.930 |
| 14/06/1991 | 18,53 | 18,81 | 18,45 | 18,81 | +2,16% | 1,93% | 4.267.037 |
| 13/06/1991 | 18,51 | 18,65 | 18,33 | 18,41 | -0,54% | 1,72% | 5.679.950 |
| 12/06/1991 | 18,33 | 18,53 | 18,01 | 18,51 | +0,76% | 2,82% | 5.131.008 |
| 11/06/1991 | 18,15 | 18,45 | 18,15 | 18,37 | +1,09% | 1,64% | 4.455.048 |
| 10/06/1991 | 18,13 | 18,33 | 18,13 | 18,17 | -0,33% | 1,10% | 2.749.742 |
| 07/06/1991 | 18,23 | 18,25 | 18,09 | 18,23 | -0,22% | 0,87% | 3.263.472 |
| 06/06/1991 | 18,49 | 18,51 | 18,27 | 18,27 | -1,18% | 1,29% | 3.040.877 |
| 05/06/1991 | 18,51 | 18,61 | 18,39 | 18,49 | -0,32% | 1,18% | 3.362.194 |
| 04/06/1991 | 18,45 | 18,65 | 18,45 | 18,55 | +0,43% | 1,08% | 4.875.086 |
| 03/06/1991 | 18,77 | 18,87 | 18,45 | 18,47 | -2,31% | 2,22% | 5.386.301 |